Recently, Shenzhen Science and Technology Innovation Commission announced the 2023 Shenzhen High-tech zone development special plan innovation platform construction project review and inspection list passed, through the data preliminary review, site inspection, reassessment and other layers of assessment, The innovation platform construction project of the achievements industrialization base declared by Shenzhen Cell Valley "Cell therapy product Research and Development and industrialization talent Training Base Construction Project based on retroviral vector technology" successfully passed the review and received the project approval notice.

The Innovation Platform construction project is a special plan set up by the government to create an excellent innovation and entrepreneurship environment in the high-tech zone, and has set up financial support for cultivating innovative enterprises with excellent competitiveness and influence, so as to guide and drive governments at all levels, enterprises and social organizations to participate in the construction and development of Shenzhen High-tech Zone. Projects that are of great strategic significance or significant contributions to scientific and technological innovation, industrial agglomeration and green development of Shenzhen High-tech Zone may be included in the special plan after approval by the municipal science and technology administrative department. The successful approval of the innovation platform of the industrialization base of Shenzhen Cell Valley represents the recognition of the influence of the government and the industry on our industry, and is expected to form a new economic growth point, become an innovative carrier to enhance the core competitiveness of the industry, and accelerate the improvement of the core competitiveness of the cell and gene therapy industry cluster.

The application project will be based on the original intention of Shenzhen Cell Valley's "cells benefit all beings, genes create the future", give full play to the absolute advantages of retroviral vector technology in reducing costs and industrial production, combined with the practical experience of Shenzhen Cell Valley in the professional field of talent training. Fully integrate scientific research with the transformation of results, guide personnel training through work practice, promote the development of cell therapy industry through talent training, build a talent training base for cell therapy drug research and development and industrialization, and commit to fundamentally solve the core challenge of cell therapy commercialization from the talent side of the industry - industrial production and manufacturing of viral vectors and talent shortage. Shorten the cycle of Chinese local cell therapy drugs from new drug development to drug listing, build cell and gene therapy enterprise incubation base, and lay a solid foundation for commercialization. Shenzhen Cell Valley will continue to innovate, improve the level of scientific research, promote the transformation and application of results, gather talent resources, help build Shenzhen characteristic park, and promote the high-quality development of the biomedical industry.